ES2173927T3 - Procedimiento para la preparacion de un concentrado de inter-alfa-tripsina inhibidor de uso terapeutico, y concentrado obtenido. - Google Patents
Procedimiento para la preparacion de un concentrado de inter-alfa-tripsina inhibidor de uso terapeutico, y concentrado obtenido.Info
- Publication number
- ES2173927T3 ES2173927T3 ES94931070T ES94931070T ES2173927T3 ES 2173927 T3 ES2173927 T3 ES 2173927T3 ES 94931070 T ES94931070 T ES 94931070T ES 94931070 T ES94931070 T ES 94931070T ES 2173927 T3 ES2173927 T3 ES 2173927T3
- Authority
- ES
- Spain
- Prior art keywords
- concentrate
- pct
- inter
- therapeutic use
- tripsin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
_LA INVENCION SE REFIERE A UN PROCEDIMIENTO DE PREPARACION DE ITI A PARTIR DE PLASMA HUMANO QUE COMPRENDE DOS ETAPAS DE CROMATOGRAFIA SOBRE GELES INTERCAMBIADORES DE ANIONES Y UNA ETAPA DE CROMATOGRAFIA DE AFINIDAD SOBRE HEPARINA INMOVILIZADA. EL PROCEDIMIENTO COMPRENDE TAMBIEN UN TRATAMIENTO DE INACTIVACION VIRAL. EL CONCENTRADO DE ITI OBTENIDO ES DE UNA CALIDAD ADAPTADA A UN USO TERAPEUTICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9312346A FR2711371B1 (fr) | 1993-10-18 | 1993-10-18 | Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2173927T3 true ES2173927T3 (es) | 2002-11-01 |
Family
ID=9451908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94931070T Expired - Lifetime ES2173927T3 (es) | 1993-10-18 | 1994-10-17 | Procedimiento para la preparacion de un concentrado de inter-alfa-tripsina inhibidor de uso terapeutico, y concentrado obtenido. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5777081A (es) |
EP (1) | EP0724600B1 (es) |
JP (1) | JP3650937B2 (es) |
AT (1) | ATE213252T1 (es) |
AU (1) | AU7996294A (es) |
CA (1) | CA2174231C (es) |
DE (1) | DE69429868T2 (es) |
DK (1) | DK0724600T3 (es) |
ES (1) | ES2173927T3 (es) |
FR (1) | FR2711371B1 (es) |
PT (1) | PT724600E (es) |
WO (1) | WO1995011260A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3626982B2 (ja) * | 1997-08-29 | 2005-03-09 | アークレイ株式会社 | タンパク質分解酵素阻害物質の測定方法およびそれに用いる測定キット |
US6596705B1 (en) | 1998-02-09 | 2003-07-22 | The Regents Of The University Of California | Inhibition of L-selectin and P-selection mediated binding using heparin |
US6660482B1 (en) | 2000-02-28 | 2003-12-09 | Rhode Island Hospital | Inter-alpha-trypsin inhibitor as a marker for sepsis |
JP2004511492A (ja) * | 2000-10-13 | 2004-04-15 | オクタファルマ アクチェン ゲゼルシャフト | ビクニンを含む血漿画分、その調製方法、およびその使用 |
WO2003088980A1 (en) * | 2002-04-18 | 2003-10-30 | Embury Stephen H | Method and composition for preventing pain in sickle cell patients |
EP3087991A1 (en) | 2003-11-08 | 2016-11-02 | Prothera Biologics | Composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
CA2726281C (en) | 2008-05-28 | 2023-04-18 | Prothera Biologics, Llc | Preparation and composition of inter-alpha inhibitor proteins from blood |
AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
WO2011150284A2 (en) | 2010-05-26 | 2011-12-01 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
WO2012012773A1 (en) | 2010-07-23 | 2012-01-26 | Baxter International Inc. | Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma |
US9572872B2 (en) | 2012-09-09 | 2017-02-21 | Prothera Biologics, Inc. | Treatment of disease using inter-alpha inhibitor proteins |
CN103880951B (zh) * | 2014-03-31 | 2016-03-30 | 南昌市万华生化制品有限公司 | 一种通过乌司他丁亲和层析介质制备纯品乌司他丁的方法 |
WO2017066683A1 (en) * | 2015-10-15 | 2017-04-20 | Plasma Technologies, Llc | Methods for extracting proteins from blood plasma |
CN109776674B (zh) * | 2019-02-19 | 2020-01-17 | 广东天普生化医药股份有限公司 | 纯化的乌司他丁及其制备方法和含有该乌司他丁的药物组合物 |
US11725043B2 (en) | 2020-03-05 | 2023-08-15 | DiaMedica USA Inc. | Ulinastatin polypeptides |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1434199A (fr) * | 1964-01-10 | 1966-04-08 | Behringwerke Ag | Procédé d'isolement d'inhibiteurs de la plasmine et de la trypsine à partir de liquides organiques d'origine humaine ou animale |
US4119774A (en) * | 1976-03-05 | 1978-10-10 | Ab Kabi | Heparin purification method |
AT368883B (de) * | 1980-07-22 | 1982-11-25 | Immuno Ag | Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen |
US4760130A (en) * | 1984-12-06 | 1988-07-26 | Synergen Biologicals, Inc. | Serine protease inhibitors and methods for isolation of same |
US4629567A (en) * | 1986-03-07 | 1986-12-16 | Smithkline-Rit | Alpha-1-antiprotease purification |
DE3877529T2 (de) * | 1987-10-23 | 1996-11-07 | Centre Regional De Transfusion | Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung. |
US5445958A (en) * | 1987-12-22 | 1995-08-29 | National Blood Authority | Process for purifying blood clotting factors |
-
1993
- 1993-10-18 FR FR9312346A patent/FR2711371B1/fr not_active Expired - Lifetime
-
1994
- 1994-10-17 WO PCT/FR1994/001197 patent/WO1995011260A1/fr active IP Right Grant
- 1994-10-17 AT AT94931070T patent/ATE213252T1/de not_active IP Right Cessation
- 1994-10-17 ES ES94931070T patent/ES2173927T3/es not_active Expired - Lifetime
- 1994-10-17 CA CA002174231A patent/CA2174231C/fr not_active Expired - Fee Related
- 1994-10-17 PT PT94931070T patent/PT724600E/pt unknown
- 1994-10-17 JP JP51140495A patent/JP3650937B2/ja not_active Expired - Fee Related
- 1994-10-17 AU AU79962/94A patent/AU7996294A/en not_active Abandoned
- 1994-10-17 US US08/632,460 patent/US5777081A/en not_active Expired - Lifetime
- 1994-10-17 DK DK94931070T patent/DK0724600T3/da active
- 1994-10-17 DE DE69429868T patent/DE69429868T2/de not_active Expired - Lifetime
- 1994-10-17 EP EP94931070A patent/EP0724600B1/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5777081A (en) | 1998-07-07 |
ATE213252T1 (de) | 2002-02-15 |
EP0724600A1 (fr) | 1996-08-07 |
AU7996294A (en) | 1995-05-08 |
PT724600E (pt) | 2002-07-31 |
WO1995011260A1 (fr) | 1995-04-27 |
FR2711371A1 (fr) | 1995-04-28 |
EP0724600B1 (fr) | 2002-02-13 |
DK0724600T3 (da) | 2002-05-27 |
JP3650937B2 (ja) | 2005-05-25 |
CA2174231C (fr) | 2004-06-01 |
FR2711371B1 (fr) | 1995-12-29 |
DE69429868T2 (de) | 2002-09-19 |
CA2174231A1 (fr) | 1995-04-27 |
DE69429868D1 (de) | 2002-03-21 |
JPH09503775A (ja) | 1997-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2173927T3 (es) | Procedimiento para la preparacion de un concentrado de inter-alfa-tripsina inhibidor de uso terapeutico, y concentrado obtenido. | |
AU7002394A (en) | Immunoglobulin g concentrate for therapeutical use and method for producing same | |
PT723538E (pt) | Compostos triciclicos de carbamato uteis para a ainibicao da funcao da proteina g e para o tratamento de doencas proliferativas | |
ATE135908T1 (de) | Optisch reines r(-)albuterol zur behandlung von asthma | |
DK1571208T3 (da) | Fremgangsmåde til ny faktor IX-rensning | |
ES2106700T3 (es) | Procedimiento para la preparacion de derivados de la 4a,5,9,10,11,12-hexahidro-6h-benzofuro(3a,3,2-ef)(2)benzacepinas. | |
NO993027D0 (no) | Pyrrolo[3,4-D]pyrimidinonderivater og deres anvendelse som legemidler | |
TW221056B (es) | ||
AU3528693A (en) | Apparatus for the heat treatment of ophthalmic lenses, especially contact lenses | |
CA2143486A1 (en) | Method of improving the immune response | |
CA2218561A1 (en) | Compounds and methods of use to treat infectious diseases | |
ES2162929T3 (es) | Procedimiento para la preparacion de 2-(1-azabiciclo(2.2.2)oct-3-il)-2,4,5,6-tetrahidro-1h-benz(de)isoquinolin-1-ona y producto intermediario. | |
WO1997018790A3 (en) | Therapeutic and diagnostic agents for the treatment of microbial infections | |
BG102064A (en) | Method for increasing the retinal blood circulation | |
CS275600B2 (en) | Method of purified albumin preparation from human or animal physiological solution | |
PT99265A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo interferon humano e metodo de tratamento de doencas proliferativas celulares | |
PT656209E (pt) | Derivados de melatonina para uso no tratamento de perturbacoes de dessincronizacao | |
NO973366L (no) | Fremgangsmåte for behandling av multippel sklerose | |
AU565799B2 (en) | 4-oxothiazolidin-2-ylidene-acetamide derivatives | |
AU3360000A (en) | Use of 4-amino pyridine for treatment of peripheral neuropathies | |
ZA986680B (en) | Thiazolobenzoheterocycles their preparation and medicaments containing them | |
AU1544497A (en) | Means for anti-rotationally fixing two components together, particularly of an osteosynthetic fixator | |
AU3406089A (en) | Novel strobilurine derivatives, their preparation and their use | |
DE69930419D1 (de) | Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie | |
ITRM940071A0 (it) | Proedimento per la riconcia delle pelli conciate. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 724600 Country of ref document: ES |